ACABU — Atlantic Coastal Acquisition II Share Price
Last trade - 00:00- $46.40m
- $45.45m
- 14
- 29
- 24
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.16 | ||
| Price to Tang. Book | 2.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -5.82% | ||
| Return on Equity | 2.7% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Abpro Holdings, Inc. is a biotechnology company dedicated to developing next-generation antibody therapeutics, which helps in improving the lives of patients with severe and life-threatening diseases. The Company is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its DiversImmune and MultiMab antibody discovery and engineering platforms, it is engaged in developing a pipeline of antibodies, both independently and through collaborations with global pharmaceutical and research institutions. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting human epidermal growth factor receptor 2 (HER2), and cluster of differentiation 3 (CD3), T-cell co-receptor.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- May 20th, 2021
- Public Since
- January 14th, 2022
- No. of Shareholders
- 9
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 8,041,269
- Address
- 6 St Johns Lane, Floor 5, NEW YORK, 10013
- Web
- https://atlantic-coastal.com/
- Phone
- +1 2488907200
- Auditors
- Marcum LLP
Similar to ACABU
Agriculture & Natural Solutions Acquisition
NASDAQ Global Market
Agriculture & Natural Solutions Acquisition
NASDAQ Global Market
Aimei Health Technology Co
NASDAQ Global Market
Aimei Health Technology Co
NASDAQ Global Market
Aimfinity Investment I
NASDAQ Global Market
FAQ
As of Today at 18:24 UTC, shares in Atlantic Coastal Acquisition II are trading at $8.05. This share price information is delayed by 15 minutes.
Shares in Atlantic Coastal Acquisition II last closed at $8.05 and the price had moved by +4.46% over the past 365 days. In terms of relative price strength the Atlantic Coastal Acquisition II share price has underperformed the S&P500 Index by -20.21% over the past year.
There is no consensus recommendation for this security.
Find out moreAtlantic Coastal Acquisition II does not currently pay a dividend.
Atlantic Coastal Acquisition II does not currently pay a dividend.
Atlantic Coastal Acquisition II does not currently pay a dividend.
To buy shares in Atlantic Coastal Acquisition II you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $8.05, shares in Atlantic Coastal Acquisition II had a market capitalisation of $46.40m.
Here are the trading details for Atlantic Coastal Acquisition II:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: ACABU
Based on an overall assessment of its quality, value and momentum Atlantic Coastal Acquisition II is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Atlantic Coastal Acquisition II. Over the past six months, its share price has underperformed the S&P500 Index by -11.11%.
As of the last closing price of $8.05, shares in Atlantic Coastal Acquisition II were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Atlantic Coastal Acquisition II PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $8.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Atlantic Coastal Acquisition II's directors